When Anthony was six months old we were referred to pediatric neurology for questionable diagnosis of cerebral palsy. One month later, Anthony began having seizures. We began seeing Shelly Flynn, ARNP, in the pediatric neurology epilepsy clinic, and Anthony was then diagnosed with infantile spasms. And so began our journey into this whole new world, new life in University of Iowa Stead Family Children’s Hospital.
- “A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of VX-659 in Combination with Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF)”, Vertex Pharmaceuticals, Inc. for $68,000.
- “A Phase 3 Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Theraphy in Subjects with Cystic Fibrosis Whoare Homozygous fo rthe F508del Mutation (F/F)”, Vertex Pharmaceuticals, Inc. for $58,000.
Dr. Widness, one of our most prolific emeritus faculty members, recently published in the Journal of Food Protection, titled “A Brief History of Milk Hygiene and It’s Impact on Infant Mortality from 1875 to 1925 and Implications for Today: A Review“. Congratulations, Dr. Widness!
Bansal M. Myocardial Disorders in the Neonate. NeoReviews. 2018:19(7).
New grant: Dr. William Terry (Hem/Onc). Improving Psych-Social Support for Adolescents and Young Adults with Cancer. Fraternal Order of Eagles, $3,000.
New grant: Dr. Jeff Segar in Neonatology. Fenoldopam to prevent renal dysfunctionin indomethacin treated preterm infants. NIH, $190,408.
The Stead Investiture Ceremony from April 2015 is embedded below.